
How three generations of leadership transformed a small plumbing business into a successful mechanical construction company
'It really catered to residential,' Jack's son, Brian Bird, says of the original logo featuring a bird sitting atop a wrench.
A neighbour across the street happened to work as a commercial artist for Loblaws, so Jack asked them to draw the logo. A vintage matchbook from that era features a bird and a wrench, with the motto: 'Our business is built on service.'
The Bird family's humble plumbing business has come a long way since it first opened its doors. Over the 54-year history, three generations of Birds have served as chief executive officer. The company's direction has evolved with each succession and the name has changed each time to reflect its offerings.
Today, it's called Bird Infrastructure and is run by current-CEO Brandon Bird, Jack Bird's grandson and a third-generation plumber. Over the years, it has shifted from a regional plumbing provider to a multi-service, multi-location company with 200 employees and a state-of-the-art 40,000-square-foot in-house fabrication shop. The company specializes in complex retrofit projects in facilities that need to continue day-to-day operations such as courthouses and hospitals.
The company's first shift happened in 1991 when Brian Bird took the company over from his father. He gradually pivoted to pursue industrial, commercial and institutional (ICI) construction work – a natural interest for him. A hands-on leader, Brian was into complex work, including retrofitting steam and process systems. By the early 2000s, the Gormley, Ont.-based company was so busy it dropped service-side offerings altogether and wholeheartedly embraced mechanical ICI.
To reflect the change, Brian renamed the company Bird Mechanical.
'When we started doing these bigger projects, people were saying, 'Jack Bird Plumbing and Heating doesn't sound like a mechanical company that can do this type of work,'' Brian says. 'So, I changed the name and we started striving towards more industrial, commercial projects.'
His push into this niche was successful. In the early aughts, Bird Mechanical had landed its biggest contract yet – a $7.7-million project to replace the chiller and cooling tower at Toronto's Hospital for Sick Children.
Brian's son, Brandon Bird, was a high school student who spent almost every weekend and summer break working for his dad. He ran equipment, moved pipe and loaded trucks.
'He would drop me off in the morning and pick me up every day on site,' Brandon, now 36, remembers. 'My dad always went out of his way to make sure I was exposed to the trade if I wanted it.'
He enjoyed it but didn't think he would join the family business. Instead, he followed his passion, attending Toronto Film School to pursue a career in filmmaking.
In 2008, when Brandon was between movie productions, he was flown down to California on behalf of his dad's company to learn how to run a new pipe-cutting machine. That trip was a pivotal moment – afterwards, Brandon walked into his father's office and said, 'Sign me up. I'll do this.'
'He had a look like he was on Punk'd,' Brandon recalls. 'He was looking around for hidden cameras, like what just happened.'
But it was no prank: in 2012, Brandon completed his Red Seal plumbing certification and gradually took on more responsibilities at the company. By the time Brian stepped into an executive chairman role in 2016, Bird Mechanical was bringing in $28-million in annual sales, and his son, Brandon, was primed to take over as the third-generation CEO.
Anticipating market needs and giving each CEO the freedom to follow their gut allowed for compounding success, according to Kerry Smith, national leader for family office services at MNP.
'Successful business leaders understand the industry and see where that industry is going,' Mr. Smith says. 'In this case, each individual was able to read the market and see where the trends were going.'
The integrated mechanical construction firm has grown significantly since Brandon took over the company. In the last decade, he has made strategic acquisitions, including a civil contractor business and a structural steel company. In 2018, Brandon took a risk and expanded into Atlantic Canada, opening an office in Dartmouth, N.S. with 40 employees.
The push came with its share of challenges. Brandon describes it as 'the biggest and most humbling learning experience.'
He would attend meetings with East Coasters who were wary of the Ontario-based company, despite its nearly 50-year history. But with each job, Bird proved its expertise and, in 2021, it landed a $12.4-million contract to upgrade Cape Breton Regional Hospital's piping to connect heating and cooling systems to new and aging facilities.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
2 minutes ago
- Globe and Mail
Former newswire employee convicted of using unpublished press releases for insider trading
Toronto-area software developer Harpreet Saini must pay more than $1.4-million in fines and spend several months in jail after pleading guilty to insider trading. The sentence announced by the Ontario Securities Commission on Wednesday ends a years-long investigation into Mr. Saini's use of unpublished corporate press releases to trade securities. The OSC tried the case in the Ontario Court of Justice in order for a jail term to be imposed. Mr. Saini admitted to accessing non-public information between May 2018 and July 2021 when he was an employee of Intrado Corporation, which owned the GlobeNewswire service at the time. GlobeNewswire is among the largest sources of corporate disclosure globally and was most recently acquired in May, 2025, by shareholder services provider Equiniti. It distributes news releases on behalf of thousands of companies based in 90 countries around the world. Mr. Saini traded securities 553 times based on information gleaned from 497 unpublished press releases, according to the OSC, resulting in illicit gains exceeding US$770,000. GlobeNewswire employees in Toronto charged with insider trading and fraud In addition to spending six months less a day in jail, his sentence also requires Mr. Saini to repay roughly $1.15-million in ill-gotten profits plus a $100,000 penalty. Provincial law also imposes a mandatory 25 per cent fine surcharge on that amount, bringing his total financial penalty to $1,436,393.66. During the course of the investigation, OSC staff discovered WhatsApp conversations between Mr. Saini and John Natividad, another former GlobeNewswire programmer, discussing possible price movements in the publicly-listed shares of companies that were preparing to issue news through the service. Court records show the two programmers had found a way around the system maintained by GlobeNewswire to track which employees clicked on news releases before they were published. Employees could hover their cursor over a partial headline to reveal the full title 'without leaving an audit trail,' OSC forensic auditor Anthony Long said in an affidavit. The case against Mr. Natividad, who was charged alongside Mr. Saini in September, 2022, remains ongoing. 'Employees who have access to confidential corporate information have a duty to safeguard that information and not misuse it for their personal benefit,' Bonnie Lysyk,' executive vice president of enforcement at the OSC, said in an statement. 'Insider trading is illegal, and it erodes investor confidence in our markets.' This is one of the first major cases to be concluded under Ms. Lysyk's tenure as the market watchdog's top enforcer. She joined the OSC in October, 2024, after spending a decade as the auditor-general of Ontario. Penalties worth more than $1-million and punishments involving jail time are both rare in securities law violations. In its most recent fiscal year, the Ontario Capital Markets Tribunal – an independent division of the OSC – issued a total of $81.6-million worth of administrative penalties, disgorgement orders and settlement amounts. Sentences involving jail time must be issued by provincial courts as the Tribunal can only impose monetary penalties and ban individuals from trading securities serving as corporate officers or directors. According to the OSC's latest annual report, Ontario courts handed down a total of 57 months worth of jail sentences for matters referred to them by the regulator during its 2023-2024 fiscal year. The OSC also has a long history of struggling to collect the fines it issues. Its current collections rate is just 4.5 per cent, meaning it receives just $4.50 for every $100 in penalties levied.


Globe and Mail
2 minutes ago
- Globe and Mail
B.C. Labour Board slams Amazon in appeal ruling
VANCOUVER, BC, Aug. 6, 2025 /CNW/ - Amazon has failed to overturn the B.C. Labour Relations Board's ruling and the company suffered a scathing indictment from the Board about its conduct during the Unifor unionization drive at the Delta B.C. facility ("YVR2").

Globe and Mail
2 minutes ago
- Globe and Mail
Speeding up generic drug approval timelines a priority, health minister says
The federal government is committed to speeding up drug approval timelines as part of Prime Minister Mark Carney's drive to improve efficiency and cut red tape, Health Minister Marjorie Michel said in an interview. The Globe and Mail reported this week on new data that showed Health Canada is increasingly failing to review generic drug applications within its 180-day target, meaning cheaper pharmaceuticals are taking longer to get to market. That is on top of Canada's historically slow timelines for all drugs, which rank among the longest in developed countries. Ms. Michel said that, while safety can't be compromised, it is clear there are ways to make the approval process more efficient and she has asked her department to report to her regularly on timelines. 'It's a priority for me,' she said in an interview Tuesday. Generic version of Ozempic, Wegovy to launch in Canada by Hims & Hers The Liberals promised in the spring election to 'significantly reduce' wait times for pharmaceuticals, which it acknowledged were longer than in other Group of Seven countries. 'By cutting red tape without compromising on safety we will cut this timeline while maintaining all relevant safety standards, supporting our research community and delivering life-saving medicines more quickly,' the Liberal campaign platform said. Health Canada has said one reason for delays in generics applications is incomplete or inadequate documentation from pharmaceutical companies. Data reported by The Globe this week showed that, in the 2024-25 fiscal year, 70 per cent of applications received a ruling in the final week before the 180-day target. In about three-quarters of those cases, the applications were rejected and Health Canada requested further information. But 90 per cent of applications were ultimately approved, leading the Canadian Generic Pharmaceutical Association, which represents generic drug makers, to argue that the early rejections are more a sign of files being picked up too late and not because of underlying deficiencies with the drugs. Ms. Michel said one relatively straightforward solution is earlier screening of applications. 'Where I can push is, yeah, we cannot take eight months to let them know' when there are paperwork issues, she said. 'If work has to be done, then the person needs to know as soon as possible.' Sandoz to reportedly offer generic weight-loss drugs in Canada at up to 70% discount Another area of improvement the minister identified is better collaboration with regulators in other countries. Most large pharmaceutical companies operate globally and have to work with regulators in other countries. They often question why Canadian regulators take longer than European peers. 'I would say also that what I'm encouraging my department to do a lot is to lean on approvals done by like-minded partners,' Ms. Michel said. 'Because if a drug is approved somewhere, we trust that [they] have the same regulations than we have or quite the same, well, maybe it can speed up the process.' Not all parts of the drug approval process are under federal control. The final stage of the pathway is when drug makers go to the pan-Canadian Pharmaceutical Alliance to negotiate pricing deals with all federal, provincial and territorial public insurance plans. In those discussions, Ottawa is one of 14 seats at the table. Ms. Michel said she is working with provincial counterparts on this issue, although it is one of many urgent health problems the system is facing. 'You know, they are overwhelmed, maybe with primary care,' she said of the provinces, adding that it is her role to bring everyone to the table and 'see how we can, you know, speed the process.' She said one of Canada's major strengths is its research sector. She said that will continue to be a focus and pointed to an announcement of $1.3-billion in research funding she and Industry Minister Mélanie Joly made in July. 'We have to deliver on this,' she said.